PMM2-CDG PerlQuest 

“We couldn’t be more excited to be working with a true innovator in Perlara. Their dedication and devotion to work with families to find cures was evident on our first call. Our daughter, Maggie, has an amazing spirit and is working hard – be it in physical therapy or in her school – on a daily basis. As parents we feel we owe it to her to do whatever we can to find a treatment and we are overjoyed to be working with Perlara on Maggie’s journey.”

— Holly and Dan Carmichael, Founders of Maggie’s PMM2-CDG Cure

Our Progress

Disease model development is in process. Updates to follow soon!

Launch your own PerlQuest

Still have questions about PerlQuests?

Follow other PerlQuests

PerlQuest updates from our Blog

World Rare Disease Day 2017

This post is dedicated to World Rare Disease Day (WRDD) 2017. It was at the WRRD four years earlier when the value proposition for Perlara crystalized in my mind. I went to NIH that frosty last day of February in order to meet with patient advocates and ask them one...

read more

Optimizing my first High Throughput Screen

I, along with Nina, performed our first high-throughput screen – well really medium-throughput but high-throughput for us – on Niemann-Pick Type C (NPC) patient-derived fibroblasts a couple of months back. We wanted to do a pilot screen with the Microsource bioactives...

read more

NPC1 KO mouse brain study

Well it has been a little while since I wrote a post, and a lot has happened since then, which I am sure you read about in our blogs and tweets. We changed our company name, partnered with Novartis and started partnering with patient groups to engineer our organisms...

read more

Perlara logo 300x108px

Join our mailing list

Translate »